TrialScience (New York, N.Y.)2006
Cancer regression in patients after transfer of genetically engineered lymphocytes.
Richard A Morgan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,319 papers cite itlatest 60 shown
this paperpooled ittrialcites it